V Square Quantitative Management LLC Takes $1.20 Million Position in Cencora, Inc. $COR

Key Points

• V Square Quantitative Management acquired a new stake of 3,542 shares in Cencora (NYSE:COR) in Q4, valued at approximately $1.20 million.
• Major institutions including Vanguard, State Street and JPMorgan boosted their holdings, leaving 97.52% institutional ownership of the company.
• CEO Robert P. Mauch sold 5,096 shares (~$1.81 million), reducing his ownership by 7.1%, while analysts hold a "Moderate Buy" consensus with a $403.17 average price target and several recent price-target upgrades.

V Square Quantitative Management LLC acquired a new stake in Cencora, Inc. (NYSE:COR - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 3,542 shares of the company's stock, valued at approximately $1,196,000.

Several other large investors also recently made changes to their positions in the stock. Vanguard Group Inc. boosted its holdings in shares of Cencora by 4.1% in the 3rd quarter. Vanguard Group Inc. now owns 23,395,547 shares of the company's stock valued at $7,311,810,000 after buying an additional 916,506 shares during the last quarter. State Street Corp boosted its holdings in shares of Cencora by 9.3% in the 3rd quarter. State Street Corp now owns 9,190,316 shares of the company's stock valued at $2,872,249,000 after buying an additional 782,911 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Cencora by 21.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,677,797 shares of the company's stock valued at $1,461,965,000 after buying an additional 821,098 shares during the last quarter. Boston Partners boosted its holdings in shares of Cencora by 2.0% in the 3rd quarter. Boston Partners now owns 4,509,165 shares of the company's stock valued at $1,409,152,000 after buying an additional 89,506 shares during the last quarter. Finally, Wellington Management Group LLP boosted its holdings in shares of Cencora by 3.0% in the 3rd quarter. Wellington Management Group LLP now owns 3,971,121 shares of the company's stock valued at $1,241,094,000 after buying an additional 115,278 shares during the last quarter. Institutional investors and hedge funds own 97.52% of the company's stock.

Insider Transactions at Cencora

In other Cencora news, CEO Robert P. Mauch sold 5,096 shares of Cencora stock in a transaction dated Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total value of $1,807,704.08. Following the transaction, the chief executive officer owned 66,726 shares in the company, valued at $23,669,713.98. The trade was a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.38% of the stock is currently owned by corporate insiders.

Cencora Stock Down 0.8%

Shares of NYSE COR opened at $322.38 on Friday. The company has a debt-to-equity ratio of 3.62, a quick ratio of 0.51 and a current ratio of 0.92. Cencora, Inc. has a 52 week low of $271.00 and a 52 week high of $377.54. The stock has a market capitalization of $62.71 billion, a P/E ratio of 38.75, a PEG ratio of 1.51 and a beta of 0.72. The stock's fifty day moving average is $346.12 and its 200 day moving average is $342.09.

Cencora (NYSE:COR - Get Free Report) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $4.08 EPS for the quarter, topping analysts' consensus estimates of $4.04 by $0.04. Cencora had a return on equity of 176.54% and a net margin of 0.50%.The company had revenue of $85.93 billion for the quarter, compared to analysts' expectations of $86.12 billion. During the same quarter last year, the business earned $3.73 earnings per share. Cencora's revenue was up 5.5% on a year-over-year basis. Sell-side analysts forecast that Cencora, Inc. will post 15.37 earnings per share for the current fiscal year.

Cencora Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were given a $0.60 dividend. The ex-dividend date was Friday, February 13th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.7%. Cencora's dividend payout ratio (DPR) is presently 28.85%.

Analysts Set New Price Targets

Several brokerages have issued reports on COR. Leerink Partners reaffirmed an "outperform" rating on shares of Cencora in a report on Tuesday, March 17th. Barclays raised their price target on Cencora from $400.00 to $425.00 and gave the company an "overweight" rating in a report on Friday, February 13th. Jefferies Financial Group raised Cencora from an "underperform" rating to a "buy" rating in a report on Thursday, January 22nd. Evercore reaffirmed an "outperform" rating on shares of Cencora in a report on Tuesday, March 17th. Finally, Wells Fargo & Company raised their price target on Cencora from $405.00 to $429.00 and gave the company an "overweight" rating in a report on Tuesday, February 10th. Twelve equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, Cencora presently has a consensus rating of "Moderate Buy" and a consensus target price of $403.17.

Cencora Profile

Cencora NYSE: COR is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company's core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.